The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tai, X. G.
Right arrow Articles by Fujiwara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tai, X. G.
Right arrow Articles by Fujiwara, H.

The Journal of Immunology, Vol 159, Issue 8 3799-3807, Copyright © 1997 by American Association of Immunologists


ARTICLES

CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis

XG Tai, K Toyooka, Y Yashiro, R Abe, CS Park, T Hamaoka, M Kobayashi, S Neben and H Fujiwara
Biomedical Research Center, Osaka University of Medical School, Japan.

The induction of full activation or death in TCR-triggered T cells depends largely on whether appropriate costimulatory signals are provided. In this study, we show that the costimulation of CD9 on naive T cells during TCR stimulation results in transient, albeit potent, activation followed by apoptosis, rather than full activation. Anti-CD9 mAb synergized with suboptimal doses of anti-CD3 mAb in inducing T cell activation. [3H]TdR incorporation determined 2 days after CD9 costimulation was as potent as that induced by CD28 costimulation. In contrast to progressive T cell proliferation induced by CD28 costimulation, CD9 costimulation led to the induction of apoptosis of once-activated T cells. Although IL-2R expression was induced significantly earlier and to a greater degree after CD9 costimulation than after CD28 costimulation, CD9 costimulation only transiently produced a small amount of IL-2 and induced apparently low levels of bcl-xL compared with those observed in CD28 costimulation. Addition of rIL-2 to cultures of CD9 costimulation induced strikingly enhanced expression of bcl proteins, especially of bcl-xL, and protected TCR- stimulated T cells from apoptosis. These data indicate that CD9- mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis as the result of failure to generate a positive signal for sufficient levels of IL-2 production.


This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Pfistershammer, O. Majdic, J. Stockl, G. Zlabinger, S. Kirchberger, P. Steinberger, and W. Knapp
CD63 as an Activation-Linked T Cell Costimulatory Element
J. Immunol., November 15, 2004; 173(10): 6000 - 6008.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Murayama, J.-i. Miyagawa, K. Oritani, H. Yoshida, K. Yamamoto, O. Kishida, T. Miyazaki, S. Tsutsui, T. Kiyohara, Y. Miyazaki, et al.
CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells
J. Cell Sci., July 1, 2004; 117(15): 3379 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Tarrant, J. Groom, D. Metcalf, R. Li, B. Borobokas, M. D. Wright, D. Tarlinton, and L. Robb
The Absence of Tssc6, a Member of the Tetraspanin Superfamily, Does Not Affect Lymphoid Development but Enhances In Vitro T-Cell Proliferative Responses
Mol. Cell. Biol., July 15, 2002; 22(14): 5006 - 5018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W.-J. Won and J. F. Kearney
CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice
J. Immunol., June 1, 2002; 168(11): 5605 - 5611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Y. Zhou, Y. Yashiro-Ohtani, M. Nakahira, W. R. Park, R. Abe, T. Hamaoka, M. Naramura, H. Gu, and H. Fujiwara
Molecular Mechanisms Underlying Differential Contribution of CD28 Versus Non-CD28 Costimulatory Molecules to IL-2 Promoter Activation
J. Immunol., April 15, 2002; 168(8): 3847 - 3854.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Mestas and C. C. W. Hughes
Endothelial Cell Costimulation of T Cell Activation Through CD58-CD2 Interactions Involves Lipid Raft Aggregation
J. Immunol., October 15, 2001; 167(8): 4378 - 4385.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Witherden, R. Boismenu, and W. L. Havran
CD81 and CD28 Costimulate T Cells Through Distinct Pathways
J. Immunol., August 15, 2000; 165(4): 1902 - 1909.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
I. Tachibana and M. E. Hemler
Role of Transmembrane 4 Superfamily (TM4SF) Proteins CD9 and CD81 in Muscle Cell Fusion and Myotube Maintenance
J. Cell Biol., August 23, 1999; 146(4): 893 - 904.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Aoyama, K. Oritani, T. Yokota, J. Ishikawa, T. Nishiura, K. Miyake, Y. Kanakura, Y. Tomiyama, P. W. Kincade, and Y. Matsuzawa
Stromal Cell CD9 Regulates Differentiation of Hematopoietic Stem/Progenitor Cells
Blood, April 15, 1999; 93(8): 2586 - 2594.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-S. Park, Y. Yashiro, X.-G. Tai, K. Toyo-oka, T. Hamaoka, H. Yagita, K. Okumura, S. Neben, and H. Fujiwara
Differential Involvement of a Fas-CPP32-Like Protease Pathway in Apoptosis of TCR/CD9-Costimulated, Naive T Cells and TCR-Restimulated, Activated T Cells
J. Immunol., June 15, 1998; 160(12): 5790 - 5796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Claas, C. S. Stipp, and M. E. Hemler
Evaluation of Prototype Transmembrane 4 Superfamily Protein Complexes and Their Relation to Lipid Rafts
J. Biol. Chem., March 9, 2001; 276(11): 7974 - 7984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.